The "NGS Automation Market By Product, Sequencing Type, Application, End User - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.

The NGS Automation Market is expected to grow at a CAGR of 13.4% from 2022-2029 to reach $1.33 billion by 2029.

Following a comprehensive primary and secondary study and an in-depth analysis of the market scenario, this report provides the key drivers, constraints, challenges, and opportunities in the NGS automation market. The growth of this market is driven by factors such as the increasing R&D activities in the life sciences industry, the growing demand for NGS automation in laboratories, and the increasing prevalence of chronic diseases such as cancer.

In addition, the increasing applications of next-generation sequencing and the rising number of collaborations between companies to develop library preparation protocols are expected to provide significant growth opportunities for this market. However, the high cost of automation workstations is expected to hamper the adoption of NGS automation solutions and restrain the growth of this market. In addition, factors such as regulatory & standardization concerns in diagnostic testing and the requirement of high-skilled personnel for operating automation software are the major challenges to the growth of this market.

Market Insights

Drivers

• Growing Demand for Optimized & Streamlined NGS Workflows
• Rising Prevalence of Cancer
• Increasing Pharmaceutical R&D Investments and Healthcare Expenditures

Restraints

• High Costs of Automation Workstations

Opportunities

• Increasing Applications of Next-Generation Sequencing Technology
• Collaborations Between Vendors to Develop Library Preparation Protocols

Challenges

• Regulatory & Standardization Concerns Related to Diagnostic Testing
• Need to Train Personnel on the Use of NGS Automation Software

Companies Mentioned

• Agilent Technologies Inc. (U.S.)
• Danaher Corporation (U.S.)
• Eppendorf AG (Germany)
• Hamilton Company (U.S.)
• PerkinElmer Inc. (U.S.)
• Tecan Group Ltd. (Switzerland)
• PRIMADAG SAS (France)
• BRAND GMBH + CO KG (Germany)
• Hudson Robotics (U.S.)
• SPT Labtech (U.K.)
• Thermo Fisher Scientific Inc. (U.S.)
• F. Hoffmann-La Roche AG (Switzerland)

Scope of the Report:

NGS Automation Market, by Product

• Workstation/Robotic Platform
• Reagents & Consumables

NGS Automation Market, by Application

• Drug Discovery
• Clinical Diagnostics
• Oncology
• Infectious Diseases
• Reproductive Health
• Other Clinical Diagnostics
• Other Applications

NGS Automation Market, by Sequencing Type

• Whole Genome Sequencing
• Whole Exome Sequencing
• Targeted Genome Sequencing
• Others

NGS Automation Market, by End User

• Hospitals & Diagnostic Laboratories
• Pharmaceutical and Biotechnology Companies
• Academic Research Institutes
• Others End Users

NGS Automation Market, by Geography

• North America
• U.S.
• Canada
• Europe
• Germany
• France
• U.K.
• Italy
• Spain
• Rest of Europe (RoE)
• Asia Pacific
• China
• Japan
• India
• Rest of APAC (RoAPAC)
• Latin America
• Middle East & Africa

For more information about this report visit https://www.researchandmarkets.com/r/25c3ui

View source version on businesswire.com: https://www.businesswire.com/news/home/20220628006013/en/